Is Viatris Inc. a Contrarian Dividend Option for Your Portfolio?
Does kicking against market trends make you even more excited about investing? If so, you may want to consider drugmaker Viatris Inc. (NASDAQ: VTRS), which produces products that treat diabetes, immunology and oncology. MarketBeat.com – MarketBeat Viatris’ portfolio has a wide variety of recognized brands and branded medicines, biosimilars and consumer products. Its products, such […]